Ct-7001

Ct-7001

SCHEMBL31249484

CC(C)c1cnn2c(NCc3ccccc3)cc(NCC3CCNCC3O)nc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 16/20 1.00
▸ CDK2 P24941 13/20 1.00
▸ CCNE1 P24864 8/20 1.00
▸ CCNH P51946 8/20 1.00
▸ MNAT1 P51948 7/20 1.00
▸ CDK1 P06493 7/20 1.00
▸ CDK9 P50750 7/20 1.00
▸ CDK4 P11802 4/20 1.00
▸ CDK6 Q00534 4/20 1.00
▸ CDK5 Q00535 4/20 1.00
▸ CDK8 P49336 3/20 1.00
▸ CCNT1 O60563 2/20 0.56
▸ CCNB1 P14635 2/20 0.56
▸ CCND1 P24385 2/20 0.56
▸ CDK5R1 Q15078 1/20 0.56
▸ INSRR P14616 1/20 0.56
▸ MAPK3 P27361 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ CSNK1A1 P48729 1/20 0.56
▸ DYRK1A Q13627 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ct-7001 SCHEMBL17032274 1.00 CDK7 (1.00) CDK7CDK2CCNE1CCNHMNAT1
Ct-7001 SCHEMBL20016238 1.00 CDK7 (1.00) CDK7CDK2CCNE1CCNHMNAT1
Ct-7001 SCHEMBL20848165 1.00 CDK7 (1.00) CDK7CDK2CCNE1CCNHMNAT1
Ct-7001 SCHEMBL18298190 0.99 CDK7 (0.98) CDK7CDK2CCNE1CCNHMNAT1
SCHEMBL24791459 0.95 CDK7 (0.91) CDK7CDK2CCNE1CCNHMNAT1
SCHEMBL17032283 0.93 CDK7 (0.88) CDK7CDK2CCNE1CCNHMNAT1
Hydrochloric Acid SCHEMBL18298199 0.93 CDK7 (0.86) CDK7CDK2CCNE1CCNHMNAT1
SCHEMBL24964842 0.92 CDK7 (0.85) CDK7CDK2CCNE1CCNHMNAT1
SCHEMBL30209065 0.92 CDK7 (0.85) CDK7CDK2CCNE1CCNHMNAT1
SCHEMBL24964839 0.92 CDK7 (0.85) CDK7CDK2CCNE1CCNHMNAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025006569-A1 COMBINATIONS OF ESTROGEN RECEPTOR DEGRADERS AND CDK7 INHIBITORS FOR THE TREATMENT OF CANCER ARVINAS OPERATIONS, INC. (US) 2025-01-02 — — WO disclosed
Send feedback